PALATIN TECHNOLOGIES, INC. Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations
PALATIN TECHNOLOGIES, INC. (PTN) reported Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations of 300 shares for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Forfeitures and Expirations
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations · last filed 2025-11-14
- PALATIN TECHNOLOGIES, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, expirations for the quarter ending 2025-09-30 was 300.00 shares, a 88.99% decline year-over-year.
- PALATIN TECHNOLOGIES, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, expirations for the quarter ending 2025-06-30 was -2.67K shares.
- PALATIN TECHNOLOGIES, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, expirations for the quarter ending 2025-03-31 was 0.00 shares.
- PALATIN TECHNOLOGIES, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, expirations for the quarter ending 2024-12-31 was 0.00 shares.
- PALATIN TECHNOLOGIES, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, expirations for fiscal 2025 was 54.00 shares, a 86.70% decline from fiscal 2024.
- PALATIN TECHNOLOGIES, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, expirations for fiscal 2024 was 406.00 shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations 12 month as first filed |
|---|---|---|---|---|---|
| 2025-09-30 | 300.00 shares 10-Q · filed 2025-11-14 | -2.37K shares derived: sum of 2 quarters · filed 2025-11-14 | -2.37K shares derived: sum of 3 quarters · filed 2025-11-14 | -2.37K shares derived: sum of 4 quarters · filed 2025-11-14 | |
| 2025-06-30 | -2.67K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-23 | -2.67K shares derived: sum of 2 quarters · filed 2025-09-23 | -2.67K shares derived: sum of 3 quarters · filed 2025-09-23 | 54.00 shares 10-K · filed 2025-09-23 | |
| 2025-03-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-14 | 0.00 shares derived: sum of 2 quarters · filed 2025-05-14 | 2.73K shares 10-Q · filed 2025-05-14 | -14.87K shares derived: sum of 4 quarters · filed 2025-09-23 | |
| 2024-12-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-13 | 2.73K shares 10-Q · filed 2025-02-13 | -14.87K shares derived: sum of 3 quarters · filed 2025-09-23 | ||
| 2024-09-30 | 2.73K shares 10-Q · filed 2024-11-14 | -14.87K shares derived: sum of 2 quarters · filed 2025-09-23 | |||
| 2024-06-30 | -17.59K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-23 | 406.00 shares 10-K · filed 2025-09-23 | 20.30K shares 10-K · filed 2024-09-30 | ||
| 2024-03-31 | 18.00K shares 10-Q · filed 2024-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |